24hr Tracked Cold Chain Shipping•Free Shipping on Orders £120+•

Research peptide

Tesamorelin 20mg

£60.00

In stock

In stock

Earn 60 points when you buy this product
Next dispatch
  --:--:--
Dispatch cut-offs (UK time): Mon–Fri 3pm · Sat 1pm
UK delivery £4.80 · Royal Mail 24hr Tracked
Free delivery on orders over £120.00
Loyalty rewards
Earn 60 points with this product
100 points = £1 off. Join free · How it works
Affiliate programme
Earn 5% commission on every sale you refer

Tracked cold-chain shipping
Same Day Dispatch on orders before 3pm Mon–Fri, 1pm Saturday

3rd-party COAs
Published for every batch

Responsive support
Mon–Fri 9:00–17:00

Secure checkout
Encrypted payment

SKUTSM20

For laboratory research use only. Not for human or veterinary use.

Description

Tesamorelin 20mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.

Research-grade synthetic peptide supplied as a 20 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.

Licensed tesamorelin (Egrifta) is a separate prescription medicine. This vial is not that product.

Identification

Product name Tesamorelin
Also listed as trans-3-hexenoyl-GHRH(1–44)
Supplier Opti-Gen Peptides
Contents 20 mg per vial
CAS 218949-48-5
Approx. mass ~5136 Da
Class Synthetic GHRH analogue
Intended use Laboratory / in-vitro research only

Not sermorelin, CJC-1295 or unmodified GHRH.

Quality / storage

Only the lot COA applies. Store as a laboratory peptide under institutional SOP. No reconstitution or injection instructions on this page.

Published research context (not product claims)

Tesamorelin is a stabilised GHRH(1–44) analogue with an N-terminal trans-3-hexenoyl modification. Receptor papers use it as a GHRH-receptor research ligand.

Clinical-development work produced authorised medicines for specified indications. Those authorisations apply only to approved drug products.

Egrifta-type labelling for HIV-associated lipodystrophy must not be copied onto this research listing.

GHRH analogues may be WADA-restricted. There is no authorisation to market this vial as a UK medicine.

UK notice

18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.

Additional information

Weight 0.003 g
Dimensions 1.5 × 1.5 × 4 cm

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin 20mg”

Your email address will not be published. Required fields are marked *

0